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Multidrug-resistant and highly virulent Klebsiella pneu-
moniae isolates are emerging, but the clonal groups (CGs) 
corresponding to these high-risk strains have remained im-
precisely defined. We aimed to identify K. pneumoniae CGs 
on the basis of genome-wide sequence variation and to 
provide a simple bioinformatics tool to extract virulence and 
resistance gene data from genomic data. We sequenced 
48 K. pneumoniae isolates, mostly of serotypes K1 and K2, 
and compared the genomes with 119 publicly available ge-
nomes. A total of 694 highly conserved genes were includ-
ed in a core-genome multilocus sequence typing scheme, 
and cluster analysis of the data enabled precise definition 
of globally distributed hypervirulent and multidrug-resistant 
CGs. In addition, we created a freely accessible database, 
BIGSdb-Kp, to enable rapid extraction of medically and epi-
demiologically relevant information from genomic sequenc-
es of K. pneumoniae. Although drug-resistant and virulent 
K. pneumoniae populations were largely nonoverlapping, 
isolates with combined virulence and resistance features 
were detected.
Klebsiella pneumoniae is a frequent cause of nosocomial infections and has also emerged as an agent of severe 
community-acquired infections, including pyogenic liver 
abscess, pneumonia, and meningitis (1,2). The rise of anti-
microbial drug resistance in K. pneumoniae, a member of 
the ESKAPE group (Enterococcus faecium, Staphylococcus 
aureus, Klebsiella pneumoniae, Acinetobacter baumannii, 
Pseudomonas aeruginosa, and Enterobacter species) of bac-
terial pathogens (3), raises serious therapeutic challenges. 
Most multidrug-resistant (MDR) K. pneumoniae isolates, 
which produce extended-spectrum β-lactamases (ESBLs) 
and/or carbapenemases in combination with quinolone and 
aminoglycoside resistance, belong to particular clones (4–6). 
Invasive community-acquired isolates are predominantly 
of capsular serotypes K1 and K2 and appear to differ in 
clonal background from MDR isolates (7–11). Controlling 
the emergence of these 2 types of high-risk clones and miti-
gating the alarming prospect of strains that would combine 
high virulence with multidrug resistance requires a precise 
definition of clonal groups (CGs) and rapid identification of 
their medically relevant features. K. pneumoniae clones have 
been recognized so far by using multilocus sequence typing 
(MLST) based on 7 housekeeping genes (4,8,12). However, 
MLST fails to draw clear discontinuities between CGs (4–
6). Rapid, high-throughput sequencing promises to revolu-
tionize medical microbiology and molecular epidemiology 
(13,14) by improving discriminatory power and providing 
access to the resistome and virulome of clinical isolates. 
However, it remains challenging to extract medically rel-
evant information from genome sequences in a timely man-
ner. The objectives of this work were to delineate precisely, 
based on genome-wide genotyping, CGs corresponding to 
highly virulent and MDR K. pneumoniae isolates; extract 
the antimicrobial drug resistance and virulence-associated 
genomic features of those CGs by using a rapid and simple 
bioinformatics tool; and detect potential dual-risk isolates 
carrying virulence and resistance genes.
Materials and Methods
Isolate Selection for Genome Sequencing
We sequenced 48 nonredundant K. pneumoniae isolates 
(Table S1, http://bigsdb.web.pasteur.fr/klebsiella/archives/
Bialek_TechnicalAppendix.pdf). Forty-two of the isolates 
were of capsular serotype K1 or K2, the 2 serotypes pre-
dominantly associated with community-acquired invasive 
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infections (2,15). To conduct genome sequencing, we used 
the HiSeq 2000 Sequencing System (Illumina, San Diego, 
CA, USA) with a 2 × 100 nt paired-end strategy (see Sup-
plemental Methods section at http://bigsdb.web.pasteur.fr/
klebsiella/archives/Bialek_TechnicalAppendix.pdf).
Genomes from Sequence Databases
Genomic sequences available as of July 15, 2013, for 
the entries Klebsiella, K. pneumoniae, and K. variicola, 
were downloaded from the NCBI (National Center for 
Biotechnology Information) genome sequence repository 
(http://www.ncbi.nlm.nih.gov/genome/). The downloaded 
sequences comprised 7 complete genomes and 115 
whole-genome shotgun sequences available as scaffolds 
or contigs. Of these 115 draft genomes, 2 were discarded 
because of the poor quality of assembly and 1 was dis-
carded because it corresponded in fact to the more distant 
species K. oxytoca. Thus, a total of 119 publicly available 
genome sequences were included (Table S1, http://big-
sdb.web.pasteur.fr/klebsiella/archives/Bialek_Technical 
Appendix.pdf).
Serotype Determination and MLST Data Generation
The capsular serotype was determined by PCR, us-
ing K1- and K2-specific PCR primers (15). The serotype 
of some comparative isolates was initially determined by 
using classical serology methods and/or by determining 
their C-pattern (8). MLST data were generated by using the 
international K. pneumoniae MLST typing scheme (8,12).
Definition of MLST and Core Genome MLST  
(cgMLST) Schemes
A set of 634 genes, defined as the strict cgMLST set, 
was obtained by using stringent conservation and synteny 
criteria to maximize typeability and to minimize paralo-
gous or xenologous loci (see Supplemental Methods sec-
tion at http://bigsdb.web.pasteur.fr/klebsiella/archives/
Bialek_TechnicalAppendix.pdf). Two typing schemes, 
defined as sets of predefined loci, were implemented by us-
ing the BIGSdb genome database software (16) in a newly 
created database named BIGSdb-Kp (http://bigsdb.web.
pasteur.fr). First, the MLST scheme, with its reference se-
quences and sequence types (STs), was imported from the 
international MLST database (http://www.pasteur.fr/mlst) 
into BIGSdb-Kp, which now acts as the reference. Second, 
a 694-gene cgMLST scheme was defined as the combina-
tion of the 7 MLST genes, the 53 ribosomal MLST genes 
(17), and the 634 strict cgMLST genes.
Genes Associated with Virulence and Heavy Metal 
Resistance or with Drug Resistance
Sequences of genes previously associated with viru-
lence or heavy metal resistance were used to define 
virulence-associated loci, and all currently described vari-
ants of major antimicrobial drug resistance determinants 
(namely, β-lactamases, aminoglycoside resistance–confer-
ring enzymes and fluoroquinolone-resistance loci) were in-
cluded in the BIGSdb-Kp database. For selected strains, the 
antimicrobial drug resistance phenotype was analyzed by 




Phylogenetic networks were constructed by using 
SplitsTree v4.13.1 (18) based on comparison of allelic 
profiles using distance matrices corresponding to the per-
centage of distinct loci (excluding missing alleles), which 
were obtained using BioNumerics v6.6 (Applied-Maths, 
Sint-Martens-Latem, Belgium). Clonal complexes (CCs) 
were defined as groups for which MLST profiles showed 
only 1 allelic mismatch with at least 1 other member of 
the group. Phylogenetic reconstruction based on cgMLST 
genes was performed by using minimum evolution analysis 
after discarding putative homologous recombination biases 
(see Supplemental Methods section at http://bigsdb.web.
pasteur.fr/klebsiella/archives/Bialek_TechnicalAppendix.
pdf). Selected genomes were annotated by using the Micro-
Scope annotation and comparative genomics platform (19).
Data Availability
The annotated genomic sequences of strains BJ1-GA, 
T69, SA1, and cur15505 (SB2390) were deposited in the 
European Nucleotide Archive (ENA) and are available un-
der accession nos. CBTU010000000, CBTV010000000, 
CBTW010000000, and CCBO010000000, respectively. 
The sequences of CIP 52.145 chromosome and plasmids are 
available under accession nos. FO834904 and FO834905 
and FO834906, respectively. Sequence reads correspond-
ing to the remaining 43 isolates have been deposited in the 
ENA Sequence Read Archive under study accession nos. 
ERS500935–ERS500961, ERS503301–ERS503315, and 
ERS508075. The 48 assembled genomic sequences gener-
ated in this study are accessible from the BIGSdb-Kp data-
base through Institut Pasteur’s whole-genome MLST home 
page (http://bigsdb.web.pasteur.fr).
Results
Diversity of Virulent and MDR K. pneumoniae  
Isolates as Determined by MLST
The average number of contigs and the N50 (i.e., the 
length for which half of the bases of a draft genome are 
situated in contigs of that length or longer) of the 48 ge-
nomes generated in the present study were similar to those 
of the 112 publicly available draft genomes (Table S2, 
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http://bigsdb.web.pasteur.fr/klebsiella/archives/Bialek_
TechnicalAppendix.pdf). These 2 characteristics quan-
tify the level of fragmentation of the sequence assemblies. 
MLST allele sequences were retrieved from genomic se-
quences imported into the BIGSdb-Kp database. For 46 of 
the 48 sequenced strains, MLST alleles were also obtained 
by the classical Sanger sequencing method, which, in all 
cases, confirmed the genomic data. This result corresponds 
to <1 error in 138,552 nt (i.e., 0.00072%), demonstrating 
the high quality of consensus base calls in the assemblies.
Forty-three different STs were found in the entire da-
taset. Among the isolates we sequenced, the 20 K1 isolates 
represented 2 STs, among which ST23 (n = 18) predomi-
nated, whereas the 22 K2 isolates represented 10 distinct 
STs, among which ST380 (n = 5) and ST86 (n = 6) predom-
inated (Table S1, http://bigsdb.web.pasteur.fr/klebsiella/ar-
chives/Bialek_TechnicalAppendix.pdf). Isolates belonging 
to these 3 predominant STs, as well as ST57, ST65, and 
ST375, were previously reported from invasive infections 
(7–11,20). Reference strains NTUH-K2044 and CG43 
were found to belong to ST23 and ST86, respectively. Pub-
licly available genomes predominantly included (85/119, 
71%) STs previously associated with multidrug resistance: 
ST11, ST14, ST15, ST258, and ST512 (4,5,21,22). There-
fore, the dataset comprised multiple representative isolates 
of both types of high-risk K. pneumoniae.
Definition of CGs based on cgMLST
Sequences corresponding to the 694 cgMLST loci were 
extracted from the 167 genomes by using BIGSdb, and 
allelic profiles were compared (Figure 1). Sharp disconti-
nuities were apparent: groups of isolates were clustered in 
homogeneous branches that were well separated from other 
groups. These results demonstrate the existence of clearly 
delineated K. pneumoniae clones. To define CGs nonarbi-
trarily, we analyzed the distribution of the number of al-
lelic mismatches (loci at which sequences differ) among all 
pairs of genomes (Figure S1, http://bigsdb.web.pasteur.fr/
klebsiella/archives/Bialek_TechnicalAppendix.pdf). The 
results showed a high number of genome pairs with <100 
mismatches or 500–600 mismatches; almost no genome 
pairs had 100–300 mismatches. Therefore, we propose to 
define K. pneumoniae cgMLST CGs a groups of cgMLST 
profiles having <100 allelic mismatches (i.e., 14.4% of the 
694 alleles) with at least 1 other member of the group.
By using this definition, we defined 14 CGs (Figure 
1). The MDR-associated ST258 and its MLST single-lo-
cus variants belonged to a single well-demarcated group, 
designated CG258. On the basis of MLST results, ST258 
was previously associated with many other STs in a single 
heterogeneous CC (4,6). We showed that most of these 
STs do not belong to CG258, demonstrating the power of 
cgMLST to discard spurious MLST associations. With-
in CG258, isolates of ST258 and ST512 formed a main 
cluster with, on average, only 2.1% allelic mismatches, 
whereas strains of ST11 and ST340 differed from this 
cluster by 11.0%, indicating genetic substructure within 
this CG. The other CC associated with multidrug resis-
tance, CC14 (5), was split into 2 distinct CGs: CG14 and 
CG15 (Figure 1).
Figure 1. Phylogenetic network of the 
167 Klebsiella pneumoniae genomes 
as determined on the basis of the 
allelic profiles of the 694 core genome 
multilocus sequence typing (cgMLST) 
genes. The network was constructed 
by using the neighbor-net method 
implemented in SplitsTree v4.13.1 
(18). Nodes are colored according 
to the clonal group (CG). Only the 10 
most relevant CGs are highlighted; 
note that ST35 was subdivided 
into 2 CGs (CG35-A and CG35-B). 
Gray shading indicates CG258. 
Gray dots indicate phylogroups 
KpII-B and KpIII (K. variicola). Bold 
indicates reference strains. Scale bar 
represents 100 allelic mismatches. 
ATCC, American Type Culture Col-
lection; ST, sequence type.
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Most isolates of serotype K1, which is associated 
with pyogenic liver abscess, belong to ST23 and ST57 
(7,8,11). All isolates of these 2 STs were placed together 
in CG23, a compact, clearly delineated CG. CG23 was 
highly homogeneous (3.0% distinct alleles on average), 
even though epidemiologically unrelated isolates from 
distinct continents were included (Table S1, http://bigsdb.
web.pasteur.fr/klebsiella/archives/Bialek_TechnicalAp-
pendix.pdf). This result suggests that these strains recently 
emerged from a common ancestor, which is in agreement 
with epidemiologic evidence for the recent emergence of 
liver abscess caused by K. pneumoniae (2). STs associ-
ated with serotype K2 were distributed into 3 main CGs: 
CG86, CG375, and CG380. In addition, K2 isolates of 
MLST-defined CC65 (ST25, ST65, and ST375) repre-
sented 3 distinct CGs, which differed by at least 32%. 
This result shows that MLST classification into CCs can 
conflate members of distinct CGs (Figure 2; Table S1, 
http://bigsdb.web.pasteur.fr/klebsiella/archives/Bialek_
TechnicalAppendix.pdf), and it illustrates the inability of 
MLST to reliably recognize K. pneumoniae CGs. In our 
study, the use of cgMLST demonstrated that K2 isolates 
associated with severe community-acquired infections 
are genetically more diverse than K1 isolates. The rela-
tive prevalence of these serotype K2–associated CGs, and 
the differential clinical characteristics of infections they 
cause, remain to be determined by using prospective col-
lections of isolates.
To determine the population structure of K. pneumoni-
ae, we performed phylogenetic analyses of cgMLST se-
quences (Figure 2). The results showed that most branches 
leading to CGs were long and branched deep in the tree. This 
pattern suggests an evolutionary radiation of most groups 
at approximately the same time, presumably when K. pneu-
moniae expanded into a novel niche. Whereas CG23 and 
CG380 branched off early, CG375 and CG86 were placed 
on a single branch together with ST25 and CG65, suggest-
ing a common ancestry for these 4 latter clones.
Reproducibility and Epidemiologic Relevance  
of cgMLST
One pair of public genomes in fact corresponded to the 
same strain: BAA-2146. This isolate, an MDR NDM-1–
producing isolate belonging to ST11, was independently se-
quenced twice and was assembled by using 2 distinct meth-
ods (23) (GenBank accession no. APNN01). The 2 genomic 
assemblies did not show a single allelic difference. This 
observation indicates that cgMLST is highly reproducible.
To explore the ability of cgMLST to cluster epide-
miologically associated isolates and distinguish them from 
Figure 2. Phylogenetic tree of the 167 Klebsiella pneumoniae genomes as determined on the basis of core genome multilocus sequence 
typing (cgMLST) genes and distribution of virulence and resistance features. The tree was inferred from minimum evolution analysis based 
on aligned cgMLST sequences, with K. variicola and KpII-B sequences as outgroups. Terminal branches corresponding to different taxa 
from the same clonal group (CG) or sequence type (ST) are shown as triangles of depth proportional to internal diversity. Bootstrap values 
>50% based on 1,000 gene-by-gene replicates are given at branches. Scale bar represents 0.05% estimated sequence divergence. The 
virulence and resistance gene content (indicated along the top of the figure) of identified clones is represented by squares, which are 
colored in black proportionally to the percentage of presence of a gene or cluster among members of a given CG or ST.
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other genetically closely related isolates, we included 
in our analysis 20 published genomes of isolates from a 
2011 outbreak at the National Institutes of Health Clini-
cal Center (Bethesda, Maryland, USA) (24). The outbreak 
isolates formed a unique cluster nested within the diversity 
of CG258 (Figure 3), suggesting that cgMLST may be use-
ful for short-term epidemiologic questions and outbreak in-
vestigation. Additional studies on well-defined sets of out-
breaks will be needed to define levels of variation among 
epidemiologically related and unrelated isolates.
Detection of Virulence-Associated Genes  
in K. pneumoniae Genomes
Genes previously associated with virulence and gene 
clusters coding for resistance to heavy metals, which can 
be encoded on the virulence plasmid (25), were searched 
by using BIGSdb (Figure 2; Table S3, http://bigsdb.web.
pasteur.fr/klebsiella/archives/Bialek_TechnicalAppen-
dix.pdf). The type-3 fimbriae cluster mrkABCDF was al-
most universally present, and plasmid-associated clusters 
pcoABCDERS (copper resistance) and silCERS (silver 
resistance) were widely distributed. In contrast, the other 
genes were mainly associated with particular CGs. The al-
lantoinase cluster was present only in members of CG23 
and ST25. Some or all isolates of the major CGs associ-
ated with community-acquired invasive infections (CG23, 
CG86, CG375, and CG380) harbored the 2 well-recog-
nized virulence factors iucABCDiutA (aerobactin synthe-
sis) and rmpA (the positive regulator of mucoid phenotype) 
in addition to the yersiniabactin siderophore cluster and 
(except for CG23) the 2-component system kvgAS. These 
results reinforce the view that CG23, CG86, CG375, and 
CG380 represent hypervirulent CGs of K. pneumoniae (7–
11,20,26). Several other STs and CGs (ST25, CG65, ST66 
[corresponding to the virulent K2 reference strain CIP 
52.145], ST90, and ST382) harbored virulence genes, sug-
gesting additional hypervirulent clones, which is also sup-
ported by the clinical origin of some isolates of these STs 
(Table S1, http://bigsdb.web.pasteur.fr/klebsiella/archives/
Bialek_TechnicalAppendix.pdf). In contrast, CG258 was 
almost entirely devoid of virulence genes. Microcin E492 
and colibactin synthesis clusters were present in almost all 
isolates of CG23 and CG380. These 2 secreted molecules, 
which cause damage to eukaryotic cells in vitro, may con-
tribute to the virulence of these 2 CGs.
Detection of Drug Resistance–Associated Genes  
in K. pneumoniae Genomes
We investigated the presence of genes associated with 
resistance to β-lactams, aminoglycosides, and quinolones. 
Because single amino acid changes can have medically 
relevant phenotypic effects, we searched the known pro-
tein variants of the major β-lactamase families (Figure 2; 
Table S4, http://bigsdb.web.pasteur.fr/klebsiella/archives/
Bialek_TechnicalAppendix.pdf). At least 1 variant of the 
SHV enzyme was found in 160 isolates, among which 159 
belonging to phylogroup KpI (27). The K. variicola and 
KpII-B isolates harbored blaLEN and blaOKP-B, respectively, 
Figure 3. Phylogenetic network 
of the 82 Klebsiella pneumoniae 
strains belonging to clonal group 
(CG) 258 as determined on the basis 
of the allelic profiles of the 694 core 
genome multilocus sequence typing 
(cgMLST) genes. The 20 genomes 
corresponding to isolates from the 
2011 K. pneumoniae outbreak at the 
National Institutes of Health Clinical 
Center (Bethesda, Maryland, USA) 
(24) are highlighted by gray shading. 
Scale bar represents 10 allelic 
mismatches. ST, sequence type.
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and 1 KpII-B isolate also contained the ESBL-encoding 
blaSHV-18 gene. These results are consistent with previous 
associations of K. pneumoniae phylogroups KpI, KpII, 
and KpIII with chromosomally encoded β-lactamase fami-
lies SHV, OKP, and LEN, respectively (27,28). No gene 
corresponding to a chromosomal β-lactamase was detect-
ed in the genomes of CIP 52.145 (ampicillin susceptible) 
and 4_1_44.
In addition, blaTEM and blaOXA were detected in 45 and 
80 genomes, respectively. In 48 of the latter, an internal 
stop codon was present within blaOXA-9, leading to a trun-
cated protein. This truncation was previously described 
on the multiple antimicrobial drug resistance plasmid 
pRMH712 isolated from strain 4003 (ENA accession no. 
GU553923). Nine genomes contained a gene encoding the 
ESBL CTX-M-15. As expected, all 20 genomes from the 
2011 outbreak at the National Institutes of Health Clinical 
Center were found to harbor a gene encoding the carbapen-
emase KPC-3 (24). A blaKPC gene was also detected in 62 
other genomes. Several other β-lactamase–encoding genes, 
including blaNDM-1, were detected (Table S1, http://bigsdb.
web.pasteur.fr/klebsiella/archives/Bialek_TechnicalAp-
pendix.pdf), consistent with earlier findings (29).
Regarding loci associated with resistance to quino-
lones, genes qnrB and qnrS were each present in 5 ge-
nomes, whereas a qnrA1 gene was found in the genome of 
strain 1162281, consistent with previous work (30) (Fig-
ure 2; Table S5, http://bigsdb.web.pasteur.fr/klebsiella/
archives/Bialek_TechnicalAppendix.pdf). Genes coding 
for the enzymatic targets of quinolones were detected in 
all genomes, except for gene gyrB, which was absent in 2 
genomes. The gyrA and parC genes were mutated in their 
quinolone resistance–determining region in all isolates 
of the MDR clone CG258, whereas no mutation of these 
genes was found among the hypervirulent clones. In ad-
dition, the oqxAB locus encoding an efflux pump (31) was 
detected in 163 of the 167 genomes, demonstrating that this 
locus is highly conserved in K. pneumoniae (32).
We identified 16 aminoglycoside resistance–associ-
ated loci in the genomes studied (Figure 2; Table S6, http://
bigsdb.web.pasteur.fr/klebsiella/archives/Bialek_Techni-
calAppendix.pdf). The most frequently represented gene 
(100 genomes) was ant(3″)-Ia. The aac(6′)-Ib-cr variant, 
coding for an aminoglycoside- and quinolone-modifying 
enzyme, was found in 6 genomes (Table S5, http://bigsdb.
web.pasteur.fr/klebsiella/archives/Bialek_TechnicalAp-
pendix.pdf). Genes conferring resistance to aminogly-
cosides were mainly present in the MDR clones CG258 
and CG14.
For all strains except cur15505, antimicrobial drug re-
sistance phenotypes were highly concordant with detected 
genes (Table S1, at http://bigsdb.web.pasteur.fr/klebsiella/
archives/Bialek_TechnicalAppendix.pdf). Strain cur15505 
was resistant to ceftriaxone and ceftazidime, an antimicro-
bial drug resistance phenotype compatible with the produc-
tion of an SHV-type ESBL. However, the blaSHV allele pres-
ent in this strain’s genome could not be precisely identified 
by BIGSdb-Kp because it was situated at a contig extremity.
Although isolates of hypervirulent CGs harbored al-
most no resistance genes (Figure 2), we did identify 2 iso-
lates of CG23 (BG130 and BG141) that displayed genomic 
features responsible for high-level resistance to β-lactams, 
aminoglycosides, and quinolones, as confirmed by analy-
sis of the resistance phenotype (Table S1, http://bigsdb.
web.pasteur.fr/klebsiella/archives/Bialek_TechnicalAp-
pendix.pdf). The first strain, BG130, which was isolated in 
Vietnam in 2008, contained an array of genes identical to 
a part of the Tn6061 transposon from Pseudomonas aeru-
ginosa and to the VEB-1-encoding region found in a K. 
pneumoniae isolate from Greece (33); these genes were 
blaVEB-1, ant(2″)-Ia (aadB), arr-2, cmlA5, blaOXA-10, ant(3″)-
Ia (aadA1), qacEΔ1, sulIΔ, cmlA9, tetR, and tetA. More-
over, downstream of this gene array, strain BG130 carried 
an additional region comprising gene rmtB, encoding an 
rRNA methylase, and genes blaTEM-1 and blaCTX-M-15. Strain 
BG130 also harbored gene qnrS1; the gene had the same 
surroundings as those in plasmid pHS8, which was de-
scribed in a K. pneumoniae isolate from China (34). The 
second strain, BG141, which was isolated in Madagascar 
in 2007, also carried numerous resistance genes. Those 
genes included blaCTX-M-15, blaTEM-1, blaOXA-1, aac(6′)-Ib-cr, 
and qnrB1, and the gene order was identical to that found 
in plasmids pKDO1 and pKPX-2, which were identified in 
MDR K. pneumoniae strains from the Czech Republic and 
Taiwan, respectively (35,36). These results are evocative 
of horizontal gene transfer that may have occurred between 
virulent and MDR K. pneumoniae strains.
Discussion
K. pneumoniae clinical isolates are evolving toward 
increasing levels of antimicrobial drug resistance, placing 
this species among the infectious bacterial pathogens that 
are most challenging to control (3). In parallel, even though 
most infections still occur opportunistically in debilitated 
patients, K. pneumoniae is emerging as a cause of severe 
community-acquired invasive infections (2). Recognizing 
the resistant or hypervirulent CGs is a prerequisite to better 
understand and control their global emergence. We imple-
mented a genome database for K. pneumoniae, BIGSdb-
Kp, and defined 694 genomic loci suitable for genotyping 
as well as loci associated with virulence and antimicrobial 
drug resistance. A genome-wide gene-by-gene approach 
based on the BIGSdb system (16) was previously applied 
to Neisseria meningitidis (37) and Campylobacter species 
(38). The BIGSdb system provides a simple tool for rapidly 
extracting medically relevant information.
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The detection of genes with the BIGSdb system faces 
2 limitations. First, for multicopy genes, only 1 occur-
rence might be detected. In K. pneumoniae, this problem 
is posed by the possible co-occurrence of chromosomal 
and plasmid-borne blaSHV genes. However, this issue 
has been recently addressed since version 1.8.0 (http://
sourceforge.net/p/bigsdb/news/; K. Jolley, pers. comm.). 
Second, the number of loci for which allelic number at-
tribution fails is strongly dependent on the assembly frag-
mentation (Figure S2, http://bigsdb.web.pasteur.fr/klebsi-
ella/archives/Bialek_TechnicalAppendix.pdf). Therefore, 
it seems advisable to exclude highly fragmented genomes 
from the analysis.
Several K. pneumoniae international clones associated 
with multidrug resistance or hypervirulence were described 
by using MLST (4–8,21). However, the low level of nu-
cleotide sequence divergence among K. pneumoniae iso-
lates (8) makes it difficult to define borders between clones 
(4–6). The 694-gene cgMLST genotyping scheme repre-
sents ≈100 times more sequence information than that pro-
vided by the 7-gene MLST. cgMLST demonstrated clear 
discontinuities in the K. pneumoniae genotypic space and 
showed that high-risk CGs were remarkably distinct from 
their closest genotypic neighbors. This result is in strik-
ing contrast to the genotypic continuum obtained by using 
MLST. Retrospectively, the failure of MLST to disclose 
the sharp discontinuities among CGs can be attributed to a 
severe lack of resolution.
The discovery of recognizable K. pneumoniae CGs 
opens the way to studying their genomic and biologic 
specificities. Different combinations of virulence and re-
sistance genes were found among CGs, providing identi-
fication markers and hinting that these clones had distinct 
host–pathogen relationships and antimicrobial drug expo-
sure. The genomic signatures of CGs show that MDR and 
hypervirulent populations of K. pneumoniae are, so far, 
mostly nonoverlapping. However, genes encoding resis-
tance to β-lactams, quinolones, and aminoglycosides were 
detected in 2 isolates of hypervirulent clone CG23: BG130 
(Vietnam, 2008) and BG141 (Madagascar, 2007). These 2 
isolates are among the first documented members of CG23 
shown to harbor blaCTX-M-15 and genes conferring high-
level resistance to aminoglycosides and fluoroquinolones. 
A CTX-M-15–producing ST23 strain was also reported 
from South Korea (39). These results show that the gloomy 
prospect of dual-risk K. pneumoniae strains, combining 
virulence and multidrug resistance features, is becoming 
a reality.
Genome-wide genotyping is a powerful approach to 
address fine-scale epidemiologic questions (37). Our find-
ings show that the discriminatory power of cgMLST, based 
on 694 genes, makes it possible to distinguish a subgroup 
of isolates involved in the 2011 K. pneumoniae outbreak 
in Bethesda (24) from epidemiologically unrelated CG258 
isolates. However, local epidemiologic investigations will 
require more resolution to decipher recent transmission 
events. Because the typical K. pneumoniae genome harbors 
≈5,300 genes, there is ample room for defining additional 
loci to improve discriminatory power. The BIGSdb-Kp da-
tabase can host additional loci and schemes curated at a 
distance by distinct laboratories (16).
Our findings demonstrate the existence of clearly 
distinguishable K. pneumoniae CGs and show that MDR 
and hypervirulent populations of this species are largely 
nonoverlapping. However, hypervirulent K. pneumoniae 
are beginning to evolve toward increasing levels of an-
timicrobial drug resistance and may represent a new and 
serious threat to public health (40). The freely accessible 
BIGSdb-Kp database represents a novel tool for monitor-
ing the emergence of high-risk clones and for global col-
laboration on the population biology, epidemiology, and 
pathogenesis of K. pneumoniae.
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